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Dear editor
We thank Xu et al for their interest in our study.1 First, we unfortunately did not
have access to LDL measurements which we acknowledge potentially could have
provided valuable information. We found that statin treatment increased with the
extent of coronary artery disease (CAD) which may lead to underestimation of the
actual effect of CAD extent.
Second, our dataset did not include information on HbA1c. The association
between hyperglycemia and cardiovascular risk is complex.2 Furthermore, glycemic
levels are not part of cardiovascular risk assessment in patients with diabetes since
HbA1c does not sufficiently represent the diabetes-related cardiovascular disease
severity.2
Third, we agree that the location and number of coronary lesions are important
indicators of atherosclerotic disease burden at the individual patient level. However,
at a cohort level CAD extent was strongly associated with adverse cardiovascular
events in diabetes patients. Furthermore, our study aligns with previous results that
demonstrated a clear association between the CAD extent and cardiovascular risk in
patients with diabetes after coronary angiography.3
Fourth, we did not perform analysis stratified by sex. However, we included sex
as a variable in the multivariate regression analyses in the study, thus adjusting for
the potential effect of sex. We found that sex was not strongly associated with risk
of major adverse cardiovascular events (MACE) in angiography patients. Women
only had a slightly lower risk of MACE compared to men (adjusted incidence rate
ratio 0.93, 95% CI 0.83–1.04) when accounting for additional confounders includ-
ing CAD extent.
Fifth, we agree that poly-drug usage may result in lower compliance. However,
nothing in our data indicates low drug compliance. Our data rather show that com-
pliance to anti-thrombotic treatment and statins was high in patients with CAD. While
we cannot account for actual drug ingestion in a registry setting, drug treatment results
were based on prescription dispensations. The patients would have had to actively
redeem and pay for their prescriptions at a pharmacy which strongly indicates drug
compliance. Furthermore, drug treatment was high in all patients with either 1-, 2-, or
3-vessel obstructive CAD. Any potential lack of drug compliance due to poly-drug use
would presumably be similar among these patients and, thus, cannot account for the
association between cardiovascular risk and CAD extent.
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